Stock Research: Embla Medical

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Embla Medical

CPH:EMBLA IS0000000040
40
  • Value
    34
  • Growth
    74
  • Safety
    Safety
    65
  • Combined
    67
  • Sentiment
    39
  • 360° View
    360° View
    40
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Embla Medical hf, formerly Ossur hf, develops and distributes medical equipment and supplies. It operates in non-invasive prosthetics, medical braces, and supports. Based in Iceland, they have clinics worldwide. In the last fiscal year, the company had a market cap of $2,161 million, profits of $535 million, and revenue of $855 million, with 4078 employees.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
34 30 43 45
Growth
74 68 69 87
Safety
Safety
65 38 16 15
Sentiment
39 50 61 48
360° View
360° View
40 35 44 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
11 67 40 81
Opinions Change
50 8 50 50
Pro Holdings
n/a 6 6 6
Market Pulse
75 85 88 56
Sentiment
39 50 61 48
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
34 30 43 45
Growth
74 68 69 87
Safety Safety
65 38 16 15
Combined
67 24 25 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
56 49 56 55
Price vs. Earnings (P/E)
26 42 44 35
Price vs. Book (P/B)
68 54 58 50
Dividend Yield
1 1 1 1
Value
34 30 43 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
60 64 56 52
Profit Growth
69 54 80 100
Capital Growth
70 76 67 98
Stock Returns
39 56 39 29
Growth
74 68 69 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
40 32 32 28
Refinancing
49 43 37 31
Liquidity
74 48 31 28
Safety Safety
65 38 16 15

Similar Stocks

Discover high‑ranked alternatives to Embla Medical and broaden your portfolio horizons.

STMicroelectronics

PAR:STMPA
Country: Netherlands
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Magyar Telekom

BUD:MTELEKOM
Country: Hungary
Industry: Integrated Telecommunication
Size: Medium
Full Stock Analysis

KSB

GER:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

L.D.C.

PAR:LOUP
Country: France
Industry: Packaged Foods & Meats
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: